CL2011000268A1 - Uso de dronedarona para preparar un medicamento util en la prevencion del ictus o ataque isquemico transitorio. - Google Patents
Uso de dronedarona para preparar un medicamento util en la prevencion del ictus o ataque isquemico transitorio.Info
- Publication number
- CL2011000268A1 CL2011000268A1 CL2011000268A CL2011000268A CL2011000268A1 CL 2011000268 A1 CL2011000268 A1 CL 2011000268A1 CL 2011000268 A CL2011000268 A CL 2011000268A CL 2011000268 A CL2011000268 A CL 2011000268A CL 2011000268 A1 CL2011000268 A1 CL 2011000268A1
- Authority
- CL
- Chile
- Prior art keywords
- dronedarone
- stroke
- prevention
- prepare
- transient ischemic
- Prior art date
Links
- 208000032109 Transient ischaemic attack Diseases 0.000 title abstract 2
- ZQTNQVWKHCQYLQ-UHFFFAOYSA-N dronedarone Chemical compound C1=CC(OCCCN(CCCC)CCCC)=CC=C1C(=O)C1=C(CCCC)OC2=CC=C(NS(C)(=O)=O)C=C12 ZQTNQVWKHCQYLQ-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002084 dronedarone Drugs 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 201000010875 transient cerebral ischemia Diseases 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
Abstract
Uso de dronedarona, en la prevención del ictus o ataque isquémico transitorio.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08290761A EP2153830A1 (en) | 2008-08-07 | 2008-08-07 | Use of dronedarone for the preparation of a medicament intended for the prevention of stroke or transient ischemic attack |
US8780308P | 2008-08-11 | 2008-08-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2011000268A1 true CL2011000268A1 (es) | 2011-07-29 |
Family
ID=40149599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2011000268A CL2011000268A1 (es) | 2008-08-07 | 2011-02-07 | Uso de dronedarona para preparar un medicamento util en la prevencion del ictus o ataque isquemico transitorio. |
Country Status (24)
Country | Link |
---|---|
US (1) | US20110230552A1 (es) |
EP (2) | EP2153830A1 (es) |
JP (1) | JP2011529958A (es) |
KR (1) | KR20110042344A (es) |
CN (1) | CN102149377A (es) |
AR (1) | AR073265A1 (es) |
AU (1) | AU2009278864A1 (es) |
BR (1) | BRPI0917569A2 (es) |
CA (1) | CA2733149A1 (es) |
CL (1) | CL2011000268A1 (es) |
CO (1) | CO6351721A2 (es) |
CR (1) | CR20110061A (es) |
DO (1) | DOP2011000043A (es) |
EA (1) | EA201170301A1 (es) |
EC (1) | ECSP11010811A (es) |
IL (1) | IL211098A0 (es) |
MA (1) | MA32602B1 (es) |
MX (1) | MX2011001461A (es) |
NI (1) | NI201100034A (es) |
PE (1) | PE20110706A1 (es) |
SV (1) | SV2011003827A (es) |
TW (1) | TW201010695A (es) |
UY (1) | UY32040A (es) |
WO (1) | WO2010015939A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011518785A (ja) * | 2008-04-17 | 2011-06-30 | サノフイ−アベンテイス | 心血管入院または死亡の予防に用いる薬剤を調製するためのドロネダロンの使用 |
FR2930149B1 (fr) * | 2008-04-17 | 2011-02-18 | Sanofi Aventis | Association de dronedarone avec au moins un diuretique, son application en therapeutique |
EP2116239A1 (en) * | 2008-04-29 | 2009-11-11 | Sanofi-Aventis | Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment |
AR081392A1 (es) * | 2010-05-13 | 2012-08-29 | Sanofi Aventis | Uso de dronedarona para la preparacion de un medicamento para la prevencion de hospitalizaciones cardiovasculares o muerte o sucesos cardiovasculares en pacientes con fibrilacion auricular permanente |
EP2387997A1 (en) * | 2010-05-18 | 2011-11-23 | Sanofi | Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients who developed permanent atrial fibrillation throughout the period the dronedarone is administered |
EP2387996A1 (en) * | 2010-05-17 | 2011-11-23 | Sanofi | Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients with permanent atrial fibrillation |
US8602215B2 (en) | 2010-06-30 | 2013-12-10 | Sanofi | Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation |
WO2013024411A1 (en) | 2011-08-12 | 2013-02-21 | Lupin Limited | Co-milled formulation of dronedarone |
US10603316B2 (en) | 2013-08-21 | 2020-03-31 | Morehouse School Of Medicine | Composition and methods for preventing or reducing the incidence of transient ischemic attacks |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9009389D0 (en) * | 1990-04-26 | 1990-06-20 | Smith Kline French Lab | Treatment |
FR2665444B1 (fr) | 1990-08-06 | 1992-11-27 | Sanofi Sa | Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant. |
-
2008
- 2008-08-07 EP EP08290761A patent/EP2153830A1/en not_active Withdrawn
-
2009
- 2009-08-03 PE PE2011000135A patent/PE20110706A1/es not_active Application Discontinuation
- 2009-08-03 WO PCT/IB2009/006831 patent/WO2010015939A1/en active Application Filing
- 2009-08-03 CA CA2733149A patent/CA2733149A1/en not_active Abandoned
- 2009-08-03 BR BRPI0917569A patent/BRPI0917569A2/pt not_active IP Right Cessation
- 2009-08-03 EP EP09786247A patent/EP2326324A1/en not_active Withdrawn
- 2009-08-03 MX MX2011001461A patent/MX2011001461A/es not_active Application Discontinuation
- 2009-08-03 AU AU2009278864A patent/AU2009278864A1/en not_active Abandoned
- 2009-08-03 KR KR1020117005222A patent/KR20110042344A/ko not_active Application Discontinuation
- 2009-08-03 EA EA201170301A patent/EA201170301A1/ru unknown
- 2009-08-03 CN CN200980135272XA patent/CN102149377A/zh active Pending
- 2009-08-03 JP JP2011521656A patent/JP2011529958A/ja not_active Withdrawn
- 2009-08-06 AR ARP090103009A patent/AR073265A1/es unknown
- 2009-08-06 TW TW098126633A patent/TW201010695A/zh unknown
- 2009-08-07 UY UY0001032040A patent/UY32040A/es not_active Application Discontinuation
-
2011
- 2011-02-02 CR CR20110061A patent/CR20110061A/es not_active Application Discontinuation
- 2011-02-03 DO DO2011000043A patent/DOP2011000043A/es unknown
- 2011-02-04 EC EC2011010811A patent/ECSP11010811A/es unknown
- 2011-02-04 US US13/020,889 patent/US20110230552A1/en not_active Abandoned
- 2011-02-04 SV SV2011003827A patent/SV2011003827A/es unknown
- 2011-02-06 IL IL211098A patent/IL211098A0/en unknown
- 2011-02-07 CL CL2011000268A patent/CL2011000268A1/es unknown
- 2011-02-07 NI NI201100034A patent/NI201100034A/es unknown
- 2011-02-07 CO CO11013463A patent/CO6351721A2/es not_active Application Discontinuation
- 2011-03-01 MA MA33659A patent/MA32602B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
ECSP11010811A (es) | 2011-03-31 |
WO2010015939A1 (en) | 2010-02-11 |
IL211098A0 (en) | 2011-04-28 |
CR20110061A (es) | 2011-04-04 |
EP2326324A1 (en) | 2011-06-01 |
TW201010695A (en) | 2010-03-16 |
CA2733149A1 (en) | 2010-02-11 |
MA32602B1 (fr) | 2011-09-01 |
NI201100034A (es) | 2011-10-20 |
PE20110706A1 (es) | 2011-10-11 |
EP2153830A1 (en) | 2010-02-17 |
EA201170301A1 (ru) | 2012-01-30 |
BRPI0917569A2 (pt) | 2019-09-24 |
MX2011001461A (es) | 2011-03-29 |
AU2009278864A1 (en) | 2010-02-11 |
KR20110042344A (ko) | 2011-04-26 |
CO6351721A2 (es) | 2011-12-20 |
AR073265A1 (es) | 2010-10-28 |
JP2011529958A (ja) | 2011-12-15 |
CN102149377A (zh) | 2011-08-10 |
SV2011003827A (es) | 2011-04-29 |
US20110230552A1 (en) | 2011-09-22 |
DOP2011000043A (es) | 2011-03-15 |
UY32040A (es) | 2010-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011000268A1 (es) | Uso de dronedarona para preparar un medicamento util en la prevencion del ictus o ataque isquemico transitorio. | |
GT201400147A (es) | Pirimidinas y triazinas fusionadas sustituidas y su uso | |
CO6440531A2 (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
EA200801758A1 (ru) | Лекарственные формы, устойчивые к самовольному изменению | |
BRPI0817475A2 (pt) | meio legível por computador. | |
CO6480948A2 (es) | Composición farmacéutica para la anticoncepción de emergencia | |
BR112014030275A2 (pt) | método para obter um material sólido com base em um polímero, material sólido, e, uso de material sólido. | |
BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
AR069474A1 (es) | Material anticorrosivo | |
CL2011002041A1 (es) | Compuestos derivaados de 4-isopropilfenilglucitol, inhibidores de sglt1; preparacion farmaceutica; y su uso como agente para mejorar la hiperglucemia posprandial y como agente profilactico o terapeutico para la diabetes. | |
CL2010001422A1 (es) | Uso de dronedarona para la preparacion de un medicamento util en la prevencion de la fibrilacion/aleteo auricular permanente | |
CL2014003535A1 (es) | Compuestos derivados de fenoxietil piperidina; composicion farmaceutica y uso para tratar la osteoartritis, artritis reumatoidea y el dolor asociado. | |
RS53586B1 (en) | DERIVATION OF DECISION | |
BRPI0811204A2 (pt) | Tetra-hidroibenzo-1,4-diazepinas substituídas por arila e heteroarila e uso das mesmas para bloquear a recaptação de norepinefrina, dopamina e serotonina. | |
MX2015015906A (es) | Mejoras en o con relacion a compuestos organicos. | |
BRPI0811200A2 (pt) | Tetra-hidrobenzapinas arilóxi- e heteroarilóxi-substituídas e uso das mesmas para bloquear percepção de norepinefrina, dopamina, e serotonina | |
CL2007002862A1 (es) | Uso del factor de crecimiento epidermico (egf) para tratar neuropatia sensitivo-motora, dolorosa y manifestaciones de neuritis isquemicas; composicion farmaceutica que comprende egf; y uso de la composicion antes dicha. | |
CL2014003525A1 (es) | Composicion farmaceutica que comprende fimasartan, hidroclorotiazida y un aglutinante; procedimiento de preparacion; su uso en el tratamiento de hipertension. | |
BRPI0810560A2 (pt) | Composição de bebida, processo para produzir uma composição de bebida, e, uso de uma composição de bebida. | |
CL2007002812A1 (es) | Compuestos derivados de quinolina; composicion farmaceutica, utiles para inhibir el vih. | |
ECSP10010661A (es) | Dronedarona para la prevención de la cardioversión | |
CL2012002543A1 (es) | Composicion endoparasiticida que comprende una combinacion de un compuesto de formula (i) derivado de amidoacetonitrilo y abamectina; y su uso para el control de endoparasitos, en particular helmintos. | |
CL2008001014A1 (es) | Procedimiento para preparar comprimidos de dihidrocloruro de prampipexol. | |
CR8537A (es) | Moduladores de HM74 de Oxidecahidronaftaleno | |
BR112012002311A2 (pt) | composto, composição farmacêutica, e, uso do composto. |